These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 23140295)

  • 41. miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
    Yu Y; Nangia-Makker P; Farhana L; G Rajendra S; Levi E; Majumdar AP
    Mol Cancer; 2015 May; 14():98. PubMed ID: 25928322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Roles of microRNAs in Gastrointestinal Cancer Stem Cell Resistance and Therapeutic Development.
    Hwang GR; Yuen JG; Ju J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miRNAs as Modulators of Cholesterol in Breast Cancer Stem Cells: An Approach to Overcome Drug Resistance in Cancer.
    Monchusi B; Kaur M
    Curr Drug Targets; 2022; 23(6):656-677. PubMed ID: 34629041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Flavonoid display ability to target microRNAs in cancer pathogenesis.
    Singh S; Raza W; Parveen S; Meena A; Luqman S
    Biochem Pharmacol; 2021 Jul; 189():114409. PubMed ID: 33428895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Downregulation of miR-146a promotes tumorigenesis of cervical cancer stem cells via VEGF/CDC42/PAK1 signaling pathway.
    Dong Z; Yu C; Rezhiya K; Gulijiahan A; Wang X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3711-3719. PubMed ID: 31522559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals.
    Ahmad A; Li Y; Bao B; Kong D; Sarkar FH
    Mol Nutr Food Res; 2014 Jan; 58(1):79-86. PubMed ID: 24272883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Possible carcinogenesis of tumor suppressor let-7.
    Sun X; Fan C; Du N; Ren H
    Med Hypotheses; 2013 Sep; 81(3):410-3. PubMed ID: 23790474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concise review: Emerging concepts in clinical targeting of cancer stem cells.
    Rasheed ZA; Kowalski J; Smith BD; Matsui W
    Stem Cells; 2011 Jun; 29(6):883-7. PubMed ID: 21509907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic approaches targeting cancer stem cells.
    Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
    J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer.
    Roscigno G; Puoti I; Giordano I; Donnarumma E; Russo V; Affinito A; Adamo A; Quintavalle C; Todaro M; Vivanco MD; Condorelli G
    Oncotarget; 2017 Mar; 8(12):19507-19521. PubMed ID: 28061479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The challenge of targeting cancer stem cells to halt metastasis.
    Agliano A; Calvo A; Box C
    Semin Cancer Biol; 2017 Jun; 44():25-42. PubMed ID: 28323021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polyphenol-Enriched Blueberry Preparation Controls Breast Cancer Stem Cells by Targeting FOXO1 and miR-145.
    Mallet JF; Shahbazi R; Alsadi N; Matar C
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
    Jeong JY; Kang H; Kim TH; Kim G; Heo JH; Kwon AY; Kim S; Jung SG; An HJ
    Cancer Lett; 2017 Feb; 386():168-178. PubMed ID: 27887917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review of miR-200b and cancer chemosensitivity.
    Feng B; Wang R; Chen LB
    Biomed Pharmacother; 2012 Sep; 66(6):397-402. PubMed ID: 22795796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An integrated analysis to predict micro-RNAs targeting both stemness and metastasis in human gastric cancer.
    Azimi M; Totonchi M; Rahimi M; Firouzi J; Sahranavard P; Emami Razavi A; Memari F; Kamali F; Ebrahimi M
    J Gastroenterol Hepatol; 2021 Feb; 36(2):436-445. PubMed ID: 32633423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line.
    Boo L; Ho WY; Ali NM; Yeap SK; Ky H; Chan KG; Yin WF; Satharasinghe DA; Liew WC; Tan SW; Ong HK; Cheong SK
    Int J Biol Sci; 2016; 12(4):427-45. PubMed ID: 27019627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-589-5p inhibits MAP3K8 and suppresses CD90
    Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
    J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma.
    Garzia L; Andolfo I; Cusanelli E; Marino N; Petrosino G; De Martino D; Esposito V; Galeone A; Navas L; Esposito S; Gargiulo S; Fattet S; Donofrio V; Cinalli G; Brunetti A; Vecchio LD; Northcott PA; Delattre O; Taylor MD; Iolascon A; Zollo M
    PLoS One; 2009; 4(3):e4998. PubMed ID: 19308264
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting pancreatic cancer stem cells for cancer therapy.
    Xia J; Chen C; Chen Z; Miele L; Sarkar FH; Wang Z
    Biochim Biophys Acta; 2012 Dec; 1826(2):385-99. PubMed ID: 22728049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
    Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
    EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.